Atnik 25 Tablet contains Atenolol 25 mg, a selective beta-1 adrenergic blocker widely used to manage hypertension, angina pectoris, and cardiac arrhythmias. It reduces heart rate, myocardial contractility, and cardiac output, effectively controlling elevated blood pressure and improving cardiovascular stability.
Belonging to the cardiology and antihypertensive segment, Atenolol is prescribed by cardiologists and general physicians for long-term management of cardiovascular conditions. Its selectivity ensures minimal bronchial side effects compared to non-selective beta-blockers.
The tablet is highly effective for preventing recurrent angina attacks, reducing myocardial oxygen demand, and protecting against arrhythmia-related complications, making it a staple in cardiology therapy.
For PCD pharma franchise partners, wholesalers, exporters, and third-party manufacturers, Atnik 25 Tablet provides a profitable B2B opportunity, catering to hospitals, clinics, and specialty pharmacies across India with steady market demand.